Overview

Gender

female

Investor Type

Investment Partner

Catherine J. Friedman is the Executive Venture Partner at GV.

Prior to that, Ms. Friedman held the position of Managing Director at Morgan Stanley from 1997 to 2006 and Head of West Coast Healthcare and Co-Head of the Biotechnology Practice at Morgan Stanley from 1993 to 2006.

Ms. Friedman has been a director of Board of XenoPort Inc., a publicly traded biopharmaceutical company, since 2007 and also serves on its Audit and Governance Committees. Ms. Friedman joined the Board of Enteromedics, a publicly traded medical device company in 2007 and also serves as the Chair of its Audit Committee.

She has been a Board member of the Boys and Girls Club of the Peninsula for seven years, where she serves on the Executive and Program committees.